The nanotech versus the biotech revolution: Sources of productivity in incumbent firm research |
| |
| Authors: | Frank T Rothaermel Marie Thursby |
| |
| Institution: | a College of Management, Georgia Institute of Technology, Atlanta, GA 30308-1149, USA
b College of Management, Georgia Institute of Technology, Atlanta, GA 30308-1149, and NBER, USA |
| |
| Abstract: | Does the adaptation of incumbent firms to new methods of inventing follow similar patterns across industries and inventions? We investigate this question in the context of the revolutionary scientific advances enabling biotechnology and nanotechnology, both of which represent inventions of methods of inventing for incumbent firms. We hypothesize that an incumbent firm's ability to exploit these new methods of invention depends initially on access to tacit knowledge on how to employ the new methods. Over time, however, as firms learn and/or the knowledge becomes codified in routine procedures or commercially available equipment, inventive output is more highly dependent on traditional R&D investments. We empirically test these hypotheses on two longitudinal samples over the 21-year time period between 1980 and 2000: 80 incumbent pharmaceutical firms generating 15,607 biotechnology patents, and 249 firms across a diverse set of industries that were granted a total of 3236 nanotechnology patents. We find broad support for our conjectures. |
| |
| Keywords: | Capability development Research productivity R& D investments Alliances and acquisitions Tacit knowledge |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
